Rockville Pike, Oct. 17, 2024 (GLOBE NEWSWIRE) — A newly published study by Fact.MR, a market research and competitive intelligence provider, mentions that revenue from the demand for infant clinical nutrition is approximated to reach a valuation of US$ 27.55 billion in 2024. The global market is projected to expand at a CAGR of 6% from 2024 to 2034.Top of FormTop of Form
Increasing focus on the value of a nutritious diet throughout infancy is driving the demand for specialized infant nutrition products. More parents have a greater understanding of the benefits of clinical nutrition for their children’s growth and development. Preterm births and rising infant death rates in some areas are driving up the need for baby clinical nutrition, particularly for products designed to sustain underweight and preterm neonates.
Click to Request a Sample of this Report for Additional Market Insights
https://www.factmr.com/connectus/sample?flag=S&rep_id=10417
The increased population of working mothers in the United States is mostly responsible for the need for newborn therapeutic nutrition products. Since nursing is not always practical for working parents, there is a greater reliance on infant formulae and other nutritional solutions, particularly those that replace breast milk. Preterm birth rates are among the highest in the country. Prematurely born newborns sometimes require specialist therapeutic nutrition to maintain their growth, which drives the market for products customized to meet their needs. The number of infants born with food allergies or intolerances, such as lactose intolerance or a cow’s milk protein allergy, is increasing the demand for hypoallergenic and specialty infant feeding formulas.
Key Takeaways from the Market Study
- The global market for infant clinical nutrition is approximated to reach a worth of US$ 49.47 billion by the end of 2034.
- Sales of infant clinical nutrition in the United States are projected to reach US$ 5.48 billion by the end of 2034.
- China is evaluated to hold a share of 48.9% of the East Asia market in 2024.
- The market in Japan is analyzed to reach a worth of US$ 1.78 billion in 2024.
- Demand for infant clinical nutrition in East Asia is projected to expand at a CAGR of 6.4% through 2034.
- Sales of milk-based products are forecasted to reach US$ 12.27 billion by the end of 2034.
“There is a growing reliance on infant formulas and other nutritional solutions because several working parents find breastfeeding to be impractical,” reports a Fact.MR analyst.
Growing Need for Efficient, Nutrient-Rich Supplements to Increase Survival Rate of Premature Babies
The World Health Organization (WHO) estimates that over 15 million preterm births occur annually. Preterm birth complications are a major cause of child mortality, with some cases being so severe as to be fatal. The need for effective, nutrient-rich supplements to raise the survival rate of preterm newborns is expanding globally. The need for baby clinical nutrition is increasing because the world’s top governments and organizations are aiming to improve the outcomes of premature deliveries.
Key Market Players of the Infant Clinical Nutrition Industry
The leading global manufacturers of the Infant Clinical Nutrition products are studied in the report & analyzed for further forecast. The key businesses include Abbott Laboratories; Baxter International Inc.; Nestlé S.A.; Danone; Meiji Holdings Co., Ltd.; Fresenius SE & Co. KGaA; Reckitt Benckiser Group Plc; Perrigo Co. Plc; Ingredion Inc.; Solace Nutrition.
Infant Clinical Nutrition Industry News & Competitive Trends in Manufacturing
Key players in the infant clinical nutrition industry are investing heavily in new technologies to improve production efficiency and optimize supply chains, responding to a steady increase in demand. By focusing on branding and advertising, they are attracting new customers while strengthening relationships with existing ones.
In October 2023, Nestlé launched a new infant nutrition formula called Sinergity, which includes a probiotic strain and six different human milk oligosaccharides (HMOs) to support infants’ development at various life stages. In July 2022, Danone S.A. introduced a new baby formula that combines dairy and plant-based ingredients to meet the needs of consumers looking for vegetarian, flexitarian, and plant-based feeding solutions.
In February 2022, Arla Foods Amba announced the launch of its milk fractionation technology called ORIGIN. Additionally, Abbott Laboratories introduced Similac 360 Total Care in November 2021, an infant formula featuring a blend of five different human milk oligosaccharides designed to support the growth and overall health of infants, including brain, digestive, and immune system development.
Get a Custom Analysis for Targeted Research Solutions
https://www.factmr.com/connectus/sample?flag=S&rep_id=10417
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the infant clinical nutrition market for 2019 to 2023 and forecast statistics for 2024 to 2034.
The study divulges the infant clinical nutrition market based on route of administration (oral administration, enteral administration, intravenous administration), and product type (milk-based, soy-based, organic, probiotic/prebiotic), across seven major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and MEA).
Discover Additional Market Insights from Fact.MR Research:
Global infant nutritional premix market stands at US$ 242.6 million and is projected to reach US$ 438.6 million by 2033. Vitamin-based infant nutritional premixes hold 35% share of the global market.
Demand for clinical nutrition market is estimated to stand at US$ 15.48 billion in 2024 and is slated to increase at a CAGR of 5.3%.
Rising demand for infant milk formula is projected to generate a valuation of US$ 6.3 billion in 2024 to US$ 22.35 billion by 2034. The market in Japan is expected to expand at a remarkable CAGR of 14%.
Global kids nutrition market is expected to reach US$ 55.1 billion in 2024 and is forecast to expand at a CAGR of 5.5%. Sales of snacks segment for kids, are estimated to account over US$ 22 billion in 2024.
Global organic infant formula market stands at US$ 20.77 billion, accelerating at a CAGR of 7.6% through 2033.
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Follow Us: LinkedIn | Twitter | Blog
